BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Wheeler Bio and MindImmune Therapeutics Sign CDMO Partnership Agreement to Support MindImmune’s Lead Alzheimer’s Prevention Program, MITI-101

  September 18, 2025

   · 

  3 min read
• Press Releases

  Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

  September 18, 2025

   · 

  5 min read
• Press Releases

  Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion

  September 18, 2025

   · 

  14 min read
• Press Releases

  Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology

  September 18, 2025

   · 

  9 min read
• Press Releases

  bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025

  September 18, 2025

   · 

  4 min read
• Press Releases

  Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina

  September 18, 2025

   · 

  3 min read
• Press Releases

  Character Biosciences Expands Leadership Team with Key Appointments and Announces Series B Extension

  September 18, 2025

   · 

  2 min read
• Press Releases

  Luxa Biotechnology Announces Publication in Cell Stem Cell Describing Positive Clinical Results for First-in-Human Clinical Trial for Dry AMD Therapy

  September 18, 2025

   · 

  2 min read
• Press Releases

  EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025

  September 18, 2025

   · 

  19 min read
• Press Releases

  Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board

  September 18, 2025

   · 

  6 min read